Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

This Says Our Favorite Biotech Is Off to the Races

Shares of a promising biotech we recommended back in February 2013 – jumped as much as 27% to a three-month high of $14.20 yesterday after the company said a new cancer drug met its main goal in a midstage clinical trial.

Its shares backtracked a bit as the day progressed but still closed 17.6% higher for the session. These shares have advanced 361% since we first told you about them. The stock has generated a peak gain of 456%, making it one of the 31 recommendations we’ve made to you that have doubled or better since we launched Private Briefing in August 2011. (More on that later…)

  • Featured Story

    Prepare for the "Alarmingly High" Threat of Recession 2013

    The International Monetary Fund (IMF) delivered a dismal report Tuesday that basically said to get a survival strategy ready now because Recession 2013 is on its way.

    In its latest "World Economic Outlook " presented in Tokyo, a kick-off to the IMF World Bank 2012 Annual Meeting, the agency cuts its forecast for overall global growth to 3.3% for the remainder of this year. It said growth in 2013 would remain lethargic at 3.6%. These estimates were down from July's forecast of 3.5% and 3.9%, respectively.

    To continue reading, please click here...
    Read More...
  • IMF and recession